303 related articles for article (PubMed ID: 34283065)
1. Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma.
Renzulli M; Ramai D; Singh J; Sinha S; Brandi N; Ierardi AM; Albertini E; Sacco R; Facciorusso A; Golfieri R
Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34283065
[TBL] [Abstract][Full Text] [Related]
2. Interventional Treatment Strategies in Intrahepatic Cholangiocarcinoma and Perspectives for Combined Hepatocellular-Cholangiocarcinoma.
Auer TA; Collettini F; Segger L; Pelzer U; Mohr R; Krenzien F; Gebauer B; Geisel D; Hosse C; Schöning W; Fehrenbach U
Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174120
[TBL] [Abstract][Full Text] [Related]
3. Locoregional Therapies of Cholangiocarcinoma.
Sommer CM; Kauczor HU; Pereira PL
Visc Med; 2016 Dec; 32(6):414-420. PubMed ID: 28229076
[TBL] [Abstract][Full Text] [Related]
4. [Local and locoregional treatment of intrahepatic cholangiocarcinoma].
Wacker F; Dewald C
Radiologe; 2022 Mar; 62(3):247-252. PubMed ID: 34981129
[TBL] [Abstract][Full Text] [Related]
5. Response evaluation of locoregional therapies in combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma versus hepatocellular carcinoma: a propensity score matched study.
Mukund A; V Srinivasan S; Rana S; Vijayaraghavan R; Patidar Y; Arora V; Jindal A; Choudhury A; Shasthry SM; Sarin SK
Clin Radiol; 2022 Feb; 77(2):121-129. PubMed ID: 34789395
[TBL] [Abstract][Full Text] [Related]
6. Locoregional therapy for cholangiocarcinoma.
Kuhlmann JB; Blum HE
Curr Opin Gastroenterol; 2013 May; 29(3):324-8. PubMed ID: 23337933
[TBL] [Abstract][Full Text] [Related]
7. Locoregional options in the management of cholangiocarcinoma: single center experience.
Baydoun H; Meirovich H; Maroun G; Coburn N; David E
Ann Palliat Med; 2021 Feb; 10(2):1784-1791. PubMed ID: 33725764
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
[TBL] [Abstract][Full Text] [Related]
9. Locoregional Therapy for Intrahepatic Cholangiocarcinoma.
Owen M; Makary MS; Beal EW
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190311
[TBL] [Abstract][Full Text] [Related]
10. Management of Intrahepatic Cholangiocarcinoma.
Kodali S; Shetty A; Shekhar S; Victor DW; Ghobrial RM
J Clin Med; 2021 May; 10(11):. PubMed ID: 34072277
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy.
Craciun L; de Wind R; Demetter P; Lucidi V; Bohlok A; Michiels S; Bouazza F; Vouche M; Tancredi I; Verset G; Garaud S; Naveaux C; Galdon MG; Gallo KW; Hendlisz A; Derijckere ID; Flamen P; Larsimont D; Donckier V
BMC Cancer; 2020 Feb; 20(1):135. PubMed ID: 32075608
[TBL] [Abstract][Full Text] [Related]
12. Role of Radioembolization for Biliary Tract and Primary Liver Cancer.
Taylor AC; Maddirela D; White SB
Surg Oncol Clin N Am; 2019 Oct; 28(4):731-743. PubMed ID: 31472916
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Intrahepatic Cholangiocarcinoma-A Multidisciplinary Approach.
Krenzien F; Nevermann N; Krombholz A; Benzing C; Haber P; Fehrenbach U; Lurje G; Pelzer U; Pratschke J; Schmelzle M; Schöning W
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053523
[TBL] [Abstract][Full Text] [Related]
14. Management of locally advanced intrahepatic cholangiocarcinoma: a narrative review.
Bressler L; Bath N; Manne A; Miller E; Cloyd JM
Chin Clin Oncol; 2023 Apr; 12(2):15. PubMed ID: 37038054
[TBL] [Abstract][Full Text] [Related]
15. Liver resection and transplantation for intrahepatic cholangiocarcinoma.
Mazzaferro V; Gorgen A; Roayaie S; Droz Dit Busset M; Sapisochin G
J Hepatol; 2020 Feb; 72(2):364-377. PubMed ID: 31954498
[TBL] [Abstract][Full Text] [Related]
16. Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial.
Kloeckner R; Ruckes C; Kronfeld K; Wörns MA; Weinmann A; Galle PR; Lang H; Otto G; Eichhorn W; Schreckenberger M; Dueber C; Pitton MB
Trials; 2014 Aug; 15():311. PubMed ID: 25095718
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in Image-Guided Locoregional Therapies for Primary Liver Tumors.
Criss CR; Makary MS
Biology (Basel); 2023 Jul; 12(7):. PubMed ID: 37508428
[TBL] [Abstract][Full Text] [Related]
18. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
[No Abstract] [Full Text] [Related]
19. Significant response to transarterial chemoembolization combined with PD-1 inhibitor and apatinib for advanced intrahepatic cholangiocarcinoma: A case report and literature review.
Zhang H; Han C; Zheng X; Zhao W; Liu Y; Ye X
J Cancer Res Ther; 2023 Aug; 19(4):1055-1060. PubMed ID: 37675736
[TBL] [Abstract][Full Text] [Related]
20. Prognostic analysis of patients with combined hepatocellular-cholangiocarcinoma after radical resection: A retrospective multicenter cohort study.
Zhang G; Chen BW; Yang XB; Wang HY; Yang X; Xie FC; Chen XQ; Yu LX; Shi J; Lu YY; Zhao HT
World J Gastroenterol; 2022 Nov; 28(41):5968-5981. PubMed ID: 36405111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
